Genneia S.A. Filed Primary
Proposed symbol GENN on New York Stock Exchange · First filed Jul 2, 2026 · CIK 1745621
Effective prospectus: F-1/A Jul 17, 2026 (0001628280-26-048569) · terms available
“We and the selling shareholders named in this prospectus (the "selling shareholders") are offering Class B shares in a global offering, which consists of (i) an international offering of Class B shares, which may (at the option of the international underwriters) be represented by American Depositary Shares, or "ADSs," in the United States of America or the "United States," and other countries outside Argentina, which we refer to as the "international offering," and (ii) a concurrent public offering registered with the Argentine Securities Commission (Comisión Nacional de Valores or "CNV") of Class B shares in Argentina, which we refer to as the "Argentine offering," and together with the international offering, the "global offering."”
What the company does
Genneia S.A. is a company incorporated under the laws of Argentina that operates in the following business segments: (i) electric power generation from wind renewable energy sources; (ii) electric power generation from solar renewable energy sources; (iii) electric power generation from conventional sources; and (iv) natural gas trading and gas transportation. The company has applied to list its American Depositary Shares on the NYSE under the symbol "GENN" and its Class B shares on BYMA in Argentina under the same symbol. It is an emerging growth company and qualifies as a controlled company under NYSE corporate governance rules.
Use of proceeds
The company estimates it will receive net proceeds from the global offering and intends to use them for general corporate purposes, which may include investing in the expansion of its operations in Argentina (including through the development of its project pipeline and/or acquisitions). The company will not receive any proceeds from the sale of Class B shares by the selling shareholders.
Underwriters
Extracted from F-1/A 0001628280-26-048569, filed Jul 17, 2026 and verified against that filing text.
Key risk factors
-
Different disclosure requirements as foreign private issuer / EGC
“As a foreign private issuer and an "emerging growth company," we will have different disclosure and other requirements than U.S. domestic registrants and non-emerging growth companies.”
-
Use of proceeds discretion
“You may not agree with how we use such net proceeds. There can be no assurance regarding the results and the effectiveness of our use of such net proceeds.”
-
Enforceability of civil liabilities
“It may be difficult to enforce civil liabilities against us or our directors or officers.”
-
Jury trial waiver for ADS holders
“ADSs holders may not be entitled to a jury trial with respect to claims arising under the deposit agreement, which could result in less favorable outcomes to the plaintiff(s) in any such action.”
-
Shareholder liability for conflicted votes
“Our shareholders may be subject to liability for certain votes of their securities.”
Financials before the first trade
The completed SEC companyfacts import produced no qualifying full-year financial history for this filer.
Filing history
| Filed | Form | Accession | |
|---|---|---|---|
| 2026-07-17 | F-1/A | 0001628280-26-048569 | View on EDGAR |
| 2026-07-02 | F-1 | 0001628280-26-046688 | View on EDGAR |